MMPs in unusual places

American Journal of Pathology

Volumn 169, Issue 4, 2006, Pages 1101-1103

  Hockenbery, David M ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 27; STROMELYSIN; STROMELYSIN 3; UNCLASSIFIED DRUG;

APOPTOSIS; CELL INTERACTION; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE MUTATION; HUMAN; LIVER CELL; LIVER CELL CARCINOMA; MYOFIBROBLAST; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PROTEIN TARGETING; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; ANIMAL; CELL NUCLEUS; CHEMISTRY; ENZYMOLOGY; GENETICS; METABOLISM; NUCLEAR LOCALIZATION SIGNAL;

ANIMALS; CELL NUCLEUS; HUMANS; MATRIX METALLOPROTEINASES; NUCLEAR LOCALIZATION SIGNALS;

EID: 38849200937     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.060553     Document Type: Note

References (32)

1. Si-Tayeb K, Monviosin A, Mazzocco C, Lepreux S, Decossas M, Cubel G, Taras D, Blanc J-F, Robinson DR, Rosenbaum J: Matrix metalloproteinase 3 is present in the cell nucleus and involved in apoptosis. Am J Pathol 2006, 169:1390-1401
2. Sternlicht MD, Werb Z: How matrix metalloproteinases regulate cell behavior. Annu Rev Dev Biol 2001, 17:463-516
3. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ: Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997, 139:1861-1872
4. English WR, Puente XS, Freije JM, Knauper V, Amour A, Merryweather A, Lopez-Otin C, Murphy G: Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2. J Biol Chem 2000, 275:14046-14055
5. Yu Q, Stamenkovic I: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev 2000, 14:163-176
6. Stocker W, Bode W: Structural features of a superfamily of zinc-endopeptidases: the metzincins. Curr Opin Struct Biol 1995, 5:383-390
7. Van Wart HE, Birkedal-Hansen H: The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 1990, 87:5578-5582
8. Nagase H: Activation mechanisms of matrix metalloproteinases. Biol Chem 1997, 378:151-160
9. Zhao WQ, Li H, Yamashita K, Guo XK, Hoshino T, Yoshida S, Shinya T, Hayakawa T: Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts. J Cell Sci 1998, 111:1147-1153
10. Ritter LM, Garfield SH, Thorgeirsson UP: Tissue inhibitor of metalloproteinases-1 (TIMP-1) binds to the cell surface and translocates to the nucleus of human MCF-7 breast carcinoma cells. Biochem Biophys Res Commun 1999, 257:494-499
11. Pei D, Weiss SJ: Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995, 375:244-247
12. Cao J, Rehemtulla A, Pavlaki M, Kozarekar P, Chiarelli C: Furin directly cleaves proMMP-2 in the trans-Golgi network resulting in a nonfunctioning proteinase. J Biol Chem 2005, 280:10974-10980
13. Golubkov VS, Chekanov AV, Doxsey SJ, Strongin AY: Centrosomal pericentrin is a direct cleavage target of membrane type-1 matrix metalloproteinase in humans but not in mice: potential implications for tumorigenesis. J Biol Chem 2005, 280:42237-42241
14. Kwan JA, Schulze CJ, Wang W, Leon H, Sariahmetoglu M, Sung M, Sawicka J, Sims DE, Sawicki G, Schulz R: Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. FASEB J 2004, 18:690-692
15. Wang W, Schulze CJ, Suarez-Pinzon WL, Dyck JR, Sawicki G, Schulz R: Intracellular action of matrix metalloproteinase-2 accounts for acute myocardial ischemia and reperfusion injury. Circulation 2002, 106:1543-1549
16. Nagase H, Fields CG, Fields GB: Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J Biol Chem 1994, 269:20952-20957
17. Smith MM, Shi L, Navre M: Rapid identification of highly active and selective substrates for stromelysin and matrilysin using bacteriophage peptide display libraries. J Biol Chem 1995, 270:6440-6449
18. An B, Dou QP: Cleavage of retinoblastoma protein during apoptosis: an interleukin 1 beta-converting enzyme-like protease as candidate. Cancer Res 1996, 56:438-442
19. Janicke RU, Walker PA, Lin XY, Porter AG: Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. EMBO J 1996, 15:6969-6978
20. Huang CY, Wu YM, Hsu CY, Lee WS, Lai MD, Lu TJ, Huang CL, Leu TH, Shih HM, Fang HI, Robinson DR, Kung HJ, Yuan CJ: Caspase activation of mammalian sterile 20-like kinase 3 (Mst3). Nuclear translocation and induction of apoptosis. J Biol Chem 2002, 277:34367-34374
21. Lee KK, Ohyama T, Yajima N, Tsubuki S, Yonehara S: MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem 2001, 276:19276-19285
22. Ura S, Masuyama N, Graves JD, Gotoh Y: Caspase cleavage of MST1 promotes nuclear translocation and chromatin condensation. Proc Natl Acad Sci USA 2001, 98:10148-10153
23. Jakobi R, McCarthy CC, Koeppel MA, Stringer DK: Caspase-activated PAK-2 is regulated by subcellular targeting and proteasomal degradation. J Biol Chem 2003, 278:38675-38685
24. Alcivar A, Hu S, Tang J, Yang X: DEDD and DEDD2 associate with caspase-8/10 and signal cell death. Oncogene 2003, 22:291-297
25. Ritter PM, Marti A, Blanc C, Baltzer A, Krajewski S, Reed JC, Jaggi R: Nuclear localization of procaspase-9 and processing by a caspase-3-like activity in mammary epithelial cells. Eur J Cell Biol 2000, 79:358-364
26. Shikama Y, U M, Miyashita T, Yamada M: Comprehensive studies on subcellular localizations and cell death-inducing activities of eight GFP-tagged apoptosis-related caspases. Exp Cell Res 2001, 264:315-325
27. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z: The stromal protease MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999, 98:137-146
28. Matrisian L: Cancer biology: extracellular proteinases in malignancy. Curr Biol 1999, 9:R776-R778
29. Truong T, Sun G, Doorly M, Wang JY, Schwartz MA: Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl. Proc Natl Acad Sci USA 2003, 100:10281-10286
30. Lewis JM, Truong TN, Schwartz MA: Integrins regulate the apoptotic response to DNA damage through modulation of p53. Proc Natl Acad Sci USA 2002, 99:3627-3632
31. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ: Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 2005, 436:123-127
32. Yan B, Wang H, Peng Y, Hu Y, Wang H, Zhang X, Chen Q, Bedford JS, Dewhirst MW, Li CY: A unique role of the DNA fragmentation factor in maintaining genomic stability. Proc Natl Acad Sci USA 2006, 103:1504-1509